01 · Process stage
PlannedSystem design and materials
Define the proposed adhesive, backing film, release liner and active ingredient compatibility.
Capabilities · Semi-solids & specialised presentations
Transdermal patches
A proposed service scope for transdermal delivery systems, connecting patch design, matrix formulation, active ingredient release mechanisms and product-specific testing.
PlannedCatalogue scope
Service statusPlanned
Planned.
Technical boundaries and readiness need confirmation before an activity could be presented as available.
Basis · Catalogue scope
- Status
- PlannedNo available service asserted
- Source-plan relationship
- Catalogue scopeProposed catalogue expansion
- Readiness
- Not establishedProduct and process evidence needed
- Facility roadmap
- First commercial batch target Q1 2028 · indicativeNot a service date
01 · Proposed service scope
Start with the product and its container.
Transdermal patches are presented as a planned service domain. The exact product, delivery mechanism, material selection and active ingredient release profile would define the scope of any such technical engagement.
The initial Boten plan identifies specific sterile formulation modules. Transdermal delivery represents a proposed catalogue extension outside that original scope, and would require separate confirmation before any service could exist.
Matrix patches, reservoir systems and micro-needle designs present distinct material and manufacturing requirements. Inclusion in a general catalogue does not establish that a particular delivery architecture would be technically feasible.
Catalogue boundary
A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.
02 · Presentation families
Match the route to the format.
| Format | Planning note | Basis | Status |
|---|---|---|---|
| Matrix transdermal patches | Drug dispersed in adhesive layer; requires scope confirmation. | Catalogue scope | Planned |
| Reservoir delivery systems | Separate drug reservoir and membrane; requires separate assessment. | Catalogue scope | Planned |
| Associated topical gelsGels & lotions | Formulations presenting different permeation and primary packaging requirements. | Catalogue scope | Planned |
| Analytical method developmentAnalytical method development | Specific release and adhesion methods would need development. | Catalogue scope | Planned |
03 · Process scope for discussion
Make the sequence and its evidence visible.
02 · Process stage
PlannedFormulation and coating
Consider blending parameters, coating uniformity and appropriate drying conditions for the proposed matrix.
03 · Process stage
PlannedPatch cutting and lamination
Establish exact dimensions, cutting tolerances and lamination sequences required for the specific presentation.
04 · Process stage
PlannedPrimary pouch packaging
Define protective foil or pouch requirements and the necessary seal integrity controls.
05 · Process stage
PlannedRelease profile testing
Connect formulation parameters to appropriate in vitro permeation and dissolution test requirements.
06 · Process stage
PlannedReview and disposition
Define required process records, analytical results and accountable decisions for any proposed batch.
Illustrative sequence
This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.
04 · Supporting services
No service stands alone.
01PlannedCatalogue scope
Primary packaging
Blisters, bottles, sachets, tubes and presentation-specific container systems.
Explore proposed scope02PlannedCatalogue scope
Analytical method development
Product-specific test methods and analytical development questions.
Explore proposed scope03PlannedCatalogue scope
Creams & ointments
Mixing, homogenisation, transfer and tube or container filling.
Explore proposed scope05 · Readiness questions
A service claim needs a defined evidence base.
- Product and delivery system
- Exact formulation, target release profile and proposed patch architecture.
- Facility and coating systems
- Relevant installed equipment, qualification status and agreed technical scope.
- Process and adhesion evidence
- Defined manufacturing parameters and appropriate validation for specific materials.
- Quality and testing
- Controlled analytical scope, data review rights and final decision boundaries.
- Regulatory context
- Applicable permissions and relevant product registrations for intended markets.
- Technical agreement
- Agreed responsibilities, disclosure terms and defined boundaries for technical cooperation.
06 · Practical questions
Before a technical discussion.
Is this service currently available?
No. The service is Planned. This page is a scope proposal and does not establish an operating transdermal patch service.
Are transdermal formats initially planned?
No. The original plan identifies sterile injectable modules. Transdermal patches represent a proposed extension requiring separate technical and administrative confirmation.
What information helps define the question?
Identify the proposed formulation, delivery mechanism, development stage, destination and technical question. Confidential data should only be shared through an agreed route.
Is there a service launch quarter?
No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.
Does a technical discussion establish supply?
No. Feasibility, scope, permissions, appropriate equipment, quality evidence and a formal agreement would need to be established before any commitment.
Professional enquiries
Discuss a defined question.
Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.